{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:11:58Z","timestamp":1760127118956,"version":"build-2065373602"},"reference-count":33,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T00:00:00Z","timestamp":1683417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union\u2019s Horizon 2020 research and innovation program","award":["951933"],"award-info":[{"award-number":["951933"]}]},{"name":"Lifecare AS, Bergen, Norway","award":["951933"],"award-info":[{"award-number":["951933"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sensors"],"abstract":"<jats:p>The Sencell sensor uses glucose-induced changes in an osmotic pressure chamber for continuous glucose measurement. A final device shall have the size of a grain of rice. The size limiting factor is the piezo-resistive pressure transducers inside the core sensor technology (resulting chamber volume: 70 \u00b5L. To achieve the necessary miniaturization, these pressure transducers were replaced by small (4000 \u00d7 400 \u00d7 150 nm\u00b3) nano-granular tunneling resistive (NTR) pressure sensors (chamber volume: 750 nL). For benchmark testing, we filled the miniaturized chamber with bovine serum albumin (BSA, 1 mM) and exposed it repeatedly to distilled water followed by 1 mM BSA solution. Thereafter, we manufactured sensors with glucose testing chemistry (ConcanavalinA\/dextran) and investigated sensor performance with dynamic glucose changes between 0 and 300 mg\/dL. Evaluation of the miniaturized sensors resulted in reliable pressure changes, both in the BSA benchmark experiment (30\u201335 mBar) and in the dynamic in vitro continuous glucose test (40\u201350 mBar). These pressure results were comparable to similar experiments with the previous larger in vitro sensors (30\u201350 mBar). In conclusion, the NTR pressure sensor technology was successfully employed to reduce the size of the core osmotic pressure chamber by more than 95% without loss in the osmotic pressure signal.<\/jats:p>","DOI":"10.3390\/s23094541","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T02:29:22Z","timestamp":1683512962000},"page":"4541","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Miniaturization of an Osmotic Pressure-Based Glucose Sensor for Continuous Intraperitoneal and Subcutaneous Glucose Monitoring by Means of Nanotechnology"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2385-0887","authenticated-orcid":false,"given":"Andreas","family":"Pf\u00fctzner","sequence":"first","affiliation":[{"name":"Lifecare AS, 5058 Bergen, Norway"},{"name":"Lifecare Nanobiosensors GmbH, 55128 Mainz, Germany"},{"name":"Lifecare Laboratories GmbH, 55128 Mainz, Germany"},{"name":"Pf\u00fctzner Science & Health Institute, 55128 Mainz, Germany"},{"name":"Institute for Internal Medicine and Laboratory Medicine, University for Digital Technologies in Medicine & Dentistry, 9516 Wiltz, Luxembourg"}]},{"given":"Barbora","family":"Tencer","sequence":"additional","affiliation":[{"name":"Lifecare AS, 5058 Bergen, Norway"}]},{"given":"Boris","family":"Stamm","sequence":"additional","affiliation":[{"name":"Lifecare Nanobiosensors GmbH, 55128 Mainz, Germany"}]},{"given":"Mandar","family":"Mehta","sequence":"additional","affiliation":[{"name":"Lifecare Nanobiosensors GmbH, 55128 Mainz, Germany"}]},{"given":"Preeti","family":"Sharma","sequence":"additional","affiliation":[{"name":"Lifecare Nanobiosensors GmbH, 55128 Mainz, Germany"}]},{"given":"Rustam","family":"Gilyazev","sequence":"additional","affiliation":[{"name":"Lifecare Nanobiosensors GmbH, 55128 Mainz, Germany"}]},{"given":"Hendrick","family":"Jensch","sequence":"additional","affiliation":[{"name":"Lifecare Laboratories GmbH, 55128 Mainz, Germany"}]},{"given":"Nicole","family":"Thom\u00e9","sequence":"additional","affiliation":[{"name":"Lifecare Laboratories GmbH, 55128 Mainz, Germany"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7415-465X","authenticated-orcid":false,"given":"Michael","family":"Huth","sequence":"additional","affiliation":[{"name":"Institute of Physics, Goethe-Universit\u00e4t, 60323 Frankfurt am Main, Germany"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,7]]},"reference":[{"key":"ref_1","unstructured":"ADA (2023). Standards of Medical Care in Diabetes. Diabetes Care, 46, S19\u2013S40."},{"key":"ref_2","first-page":"255","article-title":"Erste klinische Erfahrungen mit einem Praxistauglichen Glukosesensor (First clinical experience with a glucose sensor suitable for daily routine)","volume":"76","author":"Zick","year":"2000","journal-title":"Z. Allg. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/dom.14981","article-title":"Professional continuous glucose monitoring in patients with diabetes mellitus: A systematic review and meta-analysis","volume":"25","author":"Caruso","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jama.2016.19975","article-title":"Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: The DIAMOND randomized clinical trial","volume":"317","author":"Beck","year":"2017","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(18)30297-6","article-title":"Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): A multicentre, randomised controlled trial","volume":"391","author":"Heinemann","year":"2018","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/S0140-6736(16)31535-5","article-title":"Novel glucose-sensing technology and hypoglycemia in type 1 diabetes: A multicentre, non-masked, randomised controlled trial","volume":"388","author":"Bolinder","year":"2016","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/M16-2855","article-title":"DIAMOND Study Group. Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial","volume":"167","author":"Beck","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2016.19976","article-title":"Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: The GOLD randomized clinical trial","volume":"317","author":"Lind","year":"2017","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"538","DOI":"10.2337\/dc16-2482","article-title":"REPLACE-BG Study Group. REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes","volume":"40","author":"Aleppo","year":"2017","journal-title":"Diabetes Care"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2337\/dc19-1610","article-title":"Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study","volume":"43","author":"Charleer","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1210\/jc.2017-02498","article-title":"RESCUE Trial Investigators. Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study","volume":"103","author":"Charleer","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e000809","DOI":"10.1136\/bmjdrc-2019-000809","article-title":"Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4)","volume":"7","author":"Fokkert","year":"2019","journal-title":"BMJ Open Diabetes Res Care."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.diabres.2011.12.010","article-title":"Personal continuous glucose monitoring (CGM) in diabetes management: Review of the literature and implementation for practical use","volume":"96","author":"Joubert","year":"2012","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1177\/1932296817704446","article-title":"The Safety of Nonadjunctive Use of Continuous Glucose Monitors for Insulin Dosing: Still Not Resolved","volume":"11","author":"Shapiro","year":"2017","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/19322968211065065","article-title":"Interferences with CGM Systems: Practical Relevance?","volume":"16","author":"Heinemann","year":"2022","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Pf\u00fctzner, A., Jensch, H., Cardinal, C., Srikanthamoorthy, G., Riehn, E., and Thom\u00e9, N. (2022). Laboratory Protocol and Pilot Results for Dynamic Interference Testing of Continuous Glucose Monitoring Sensors. J. Diabetes Sci. Technol., 19322968221095573.","DOI":"10.1177\/19322968221095573"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1177\/193229681000400417","article-title":"Toward an injectable continuous osmotic glucose sensor","volume":"4","author":"Johannessen","year":"2010","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"12487","DOI":"10.1038\/ncomms12487","article-title":"Direct-write nanoscale printing of nanogranular tunnelling strain sensors for sub-micrometre cantilevers","volume":"7","author":"Dukic","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"170901","DOI":"10.1063\/5.0064764","article-title":"Living up to its potential\u2014Direct-write nanofabrication with focused electron beams","volume":"130","author":"Huth","year":"2021","journal-title":"J. Appl. Phys."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2337\/diacare.23.8.1143","article-title":"A new consensus error grid to evaluate the clinical significance of inaccuracy in the measurement of blood glucose","volume":"23","author":"Parkes","year":"2000","journal-title":"Diabetes Care"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1177\/193229681300700517","article-title":"Technical aspects of the Parkes Error Grid","volume":"7","author":"Klonoff","year":"2013","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_22","unstructured":"(2023, March 19). FDA, Available online: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/blood-glucose-monitoring-test-systems-prescription-point-care-use."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Jafarizadeh, B., Chowdhury, A.H., Khakpour, I., Pala, N., and Wang, C. (2022). Design Rules for a Wearable Micro-Fabricated Piezo-Resistive Pressure Sensor. Micromachines, 13.","DOI":"10.21203\/rs.3.rs-1242414\/v1"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Song, K., Son, H., Park, S., Lee, J., Jang, J., Lee, M., and Choi, H.J. (2021). Fabrication of Piezo-Resistance Composites Containing Thermoplastic Polyurethane\/Hybrid Filler Using 3D Printing. Sensors, 21.","DOI":"10.3390\/s21206813"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Chen, C., Zhao, X.L., Li, Z.H., Zhu, Z.G., Qian, S.H., and Flewitt, A.J. (2017). Current and Emerging Technology for Continuous Glucose Monitoring. Sensors, 1.","DOI":"10.3390\/s17010182"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"8005716","DOI":"10.1109\/TIM.2021.3122525","article-title":"Study of Qu-Based Resonant Microwave Sensors and Design of 3-D-Printed Devices Dedicated to Glucose Monitoring","volume":"70","author":"Juan","year":"2021","journal-title":"IEEE Trans. Instrum. Meas."},{"key":"ref_27","first-page":"1070","article-title":"Evaluation of the Non-Invasive Glucose Monitoring Device GlucoTrack\u00ae in Patients with Type 2 Diabetes and Subjects with Prediabetes","volume":"1","author":"Strobl","year":"2019","journal-title":"J. Diabetes Treat."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Tang, L., Chang, S.J., Chen, C.J., and Liu, J.T. (2020). Non-Invasive Blood Glucose Monitoring Technology: A Review. Sensors, 20.","DOI":"10.3390\/s20236925"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/1932296820911919","article-title":"Review of the Long-Term Implantable Senseonics Continuous Glucose Monitoring System and Other Continuous Glucose Monitoring Systems","volume":"15","author":"Joseph","year":"2021","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2337\/dc16-1525","article-title":"Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial","volume":"40","author":"Kropff","year":"2017","journal-title":"Diabetes Care."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/dia.2019.0020","article-title":"A prospective multicenter evaluation of the accuracy and safety of an implanted continuous glucose sensor: The PRECISION study","volume":"21","author":"Christiansen","year":"2019","journal-title":"Diabetes Technol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/dom.13726","article-title":"First assessment of the performance of an implantable continuous glucose monitoring system through 180 days in a primarily adolescent population with type 1 diabetes","volume":"21","author":"Aronson","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1089\/dia.2019.0449","article-title":"A Three-Way Accuracy Comparison of the Dexcom G5, Abbott Freestyle Libre Pro, and Senseonics Eversense Continuous Glucose Monitoring Devices in a Home-Use Study of Subjects with Type 1 Diabetes","volume":"22","author":"Jafri","year":"2020","journal-title":"Diabetes Technol. Ther."}],"container-title":["Sensors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8220\/23\/9\/4541\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:30:45Z","timestamp":1760124645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8220\/23\/9\/4541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,7]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["s23094541"],"URL":"https:\/\/doi.org\/10.3390\/s23094541","relation":{},"ISSN":["1424-8220"],"issn-type":[{"type":"electronic","value":"1424-8220"}],"subject":[],"published":{"date-parts":[[2023,5,7]]}}}